In vitro dissolution profile comparison and IVIVR. Carbamazepine case

Area of Science:

• Pharmaceutical Sciences
• Drug Development
• Pharmacokinetics

Background:

• Dissolution data from immediate or modified-release drug products are essential for establishing in-vitro/in-vivo relationships.
• Comparing dissolution profiles of different lots is vital when modifying a drug formulation with an established in-vitro/in-vivo association.
• Understanding pharmacokinetic implications requires meaningful comparison of dissolution profiles.

Purpose of the Study:

• To demonstrate a model-dependent approach for comparing dissolution profiles.
• To assess the similarity or dissimilarity of dissolution profiles between test and reference drug lots.
• To provide insight into pharmacokinetic consistency following formulation modifications.

Main Methods:

• Utilized carbamazepine tablet dissolution data as an example.
• Selected a mathematical function to describe dissolution data from standard lots.
• Constructed a similarity region based on model parameter variances.
• Calculated statistical distance between mean parameters of test and reference lots.
• Generated a confidence region around the normalized mean statistical distance for comparison.

Main Results:

• A model-dependent method for dissolution profile comparison was successfully demonstrated.
• The approach allows for quantitative assessment of similarity between drug lots.
• The method can identify significant differences in dissolution profiles, indicating potential pharmacokinetic variations.

Conclusions:

• The model-dependent dissolution profile comparison approach provides a robust method for evaluating formulation changes.
• This technique aids in ensuring pharmacokinetic consistency between different drug product lots.
• It is a valuable tool for pharmaceutical companies during drug development and post-approval changes.